Etanercept With IVIg for Acute Kawasaki Disease: A Randomized Controlled Trial
Michael A. Portman, Nagib Dahdah(HTC (Taiwan)), April Slee(Aptevo Therapeutics (United states)), Aaron Olson(University of Washington), Nadine Choueiter(Children's Hospital at Montefiore), Sujatha Buddhe(Seattle Children's Hospital), Brian D. Soriano(Seattle Children's Hospital), Carolyn A. Altman
Cited by 82
Related Papers
Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease
|Nature Genetics|2011|355
New Equations and a Critical Appraisal of Coronary Artery Z Scores in Healthy Children
|Journal of the American Society of Echocardiography|2010|309
Assessing Cardiac Metabolism
|Circulation Research|2016|284
All-Cause Mortality and Cardiovascular Outcomes With Prophylactic Steroid Therapy in Duchenne Muscular Dystrophy
|Journal of the American College of Cardiology|2013|220
Deep feature learning for automatic tissue classification of coronary artery using optical coherence tomography
|Biomedical Optics Express|2017|132